Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic cold agglutinin disease]

S Berentsen1

  • 1Medisinsk avdeling Fylkessjukehuset i Haugesund.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|February 10, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Neuropsychiatric disease with hematological findings].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2009
Same author

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease.

British journal of haematology·2001
Same author

Acute phase haemolysis in chronic cold agglutinin disease.

Scandinavian journal of immunology·2001
Same author

No response to cladribine in five patients with chronic cold agglutinin disease.

European journal of haematology·2000
Same author

[Clinical significance of antibodies against red blood cells].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2000
Same author

Clinical immunology of chronic cold agglutinin disease.

European journal of haematology·1999
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Chronic cold agglutinin disease, a rare hemolytic anemia, is increasingly viewed as a spectrum of clonal lymphoproliferative disorders, not distinct primary or secondary forms. This challenges traditional classifications and informs treatment strategies.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Cold agglutinin disease (CAD) is a rare hemolytic anemia.
  • Traditionally classified into idiopathic and secondary forms (associated with lymphoproliferative disorders).
  • Existing classifications suggest distinct pathogenic mechanisms for idiopathic and secondary CAD.

Observation:

  • Three cases of chronic cold agglutinin disease were identified in a population of 100,000.
  • All three patients were initially diagnosed with idiopathic autoimmune hemolytic anemia.
  • Subsequent investigations revealed underlying lymphoproliferative bone marrow disease in all cases.

Findings:

  • Chronic cold agglutinin disease may represent a spectrum of clonal lymphoproliferative disorders.
  • The distinction between primary (idiopathic) and secondary CAD may be artificial.

Related Experiment Videos

  • Lymphoproliferative disorders are a common underlying cause of CAD, even when initially undiagnosed.

    • Implications:

    • Reclassifying CAD as a spectrum of lymphoproliferative disorders impacts diagnostic approaches.
    • Therapeutic strategies for CAD should consider the potential underlying clonal lymphoproliferation.
    • Corticosteroids are generally not recommended for treating cold agglutinin disease due to limited efficacy and potential to mask underlying lymphoid malignancies.